Market research
BGA.V BioNeutra Global Corporation
V CAD Consumer Defensive
Latest close
As of 29 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 1M
- P/E ratio
- Not available
- Dividend yield
- Not available
- Beta
- 0.88
Profile
Instrument facts
- Exchange
- V
- Currency
- CAD
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- ISIN
- CA09073L1067
- Market cap
- 1M
- P/E ratio
- Not available
- Dividend yield
- Not available
- Beta
- 0.88
About
About BioNeutra Global Corporation
BioNeutra Global Corporation engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products with a focus on oligosaccharides. The company offers isomalt oligosaccharide ingredients under the VitaFiber brand for human digestive health. It operates in Canada, the United States, Australia, New Zealand, European Union, and the Asia Pacific. The company is headquartered in Vancouver, Canada.
Research context
BioNeutra Global Corporation appears in PyInvesting’s TSX Venture Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CAD
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the BGA.V discussion.
5 years, 6 months ago
BioNeutra Global Corporation is currently in a long term downtrend where the price is trading 8.5% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 0.4.
BioNeutra Global Corporation's total revenue sank by 43.7% to $6M since the same quarter in the previous year.
Its net income has increased by 92.5% to $-69K since the same quarter in the previous year.
Finally, its free cash flow fell by 75.6% to $159K since the same quarter in the previous year.
Based on the above factors, BioNeutra Global Corporation gets an overall score of 2/5.